Association between Usage of Prophylactic AYUSH Medicines and Disease Severity in COVID-19 Patients: A Retrospective Cohort Study
Homeopathy · 01.11.2024 · 113 (04) · 211-222
DOI: 10.1055/s-0044-1779693 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Homeopathy, erschienen am 01.11.2024. Verfasst von Anupriya Chaudhary und 51 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Central Council for Research in Homeopathy Headquarters, Delhi, India. Hauptthemen laut MEDLINE: COVID-19, Severity of Illness Index, Medicine, Ayurvedic, Homeopathy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Prior vaccination is often studied for its impact on individuals' post-infection prognosis. Ayurveda, Yoga, Unani, Siddha and Homeopathy (AYUSH) medicines, advised by the Government of India as prophylaxis during the first wave of the coronavirus disease 2019 (COVID-19) pandemic, were consumed by the masses in 2020. A study was therefore undertaken to observe any association between the prior usage of AYUSH prophylactic medicines and post-infection severity as reported by recovered COVID-19 individuals.
Methods
This was a retrospective, multi-centre, cohort study conducted in 21 cities of India from 5th August to 30th November 2020. Data from recovered COVID-19 patients, of either sex or any age, captured information about AYUSH prophylactic medicines intake prior to infection, disease severity, symptomatology, duration of complaints, etc. The study participants were grouped into AYUSH intake and non-intake. Primary composite outcome was the disease clinical course. Secondary clinical outcomes were the rate of and time to clinical recovery.
Results
Data of 5,023 persons were analysed. Ayurveda or homeopathic prophylactic medicines were consumed by more than half of the study participants: that is, 56.85% (n = 1,556) and 56.81% (n = 1,555) respectively. The overall adjusted protective effect (PE) of AYUSH prophylactic intake against moderate/severe forms of COVID-19 disease was 56.7% (95% confidence interval [CI], 48.7 to 63.50; p < 0.001). Adjusted PE for homeopathy and Siddha was 52.9% (95% CI, 42.30 to 61.50; p < 0.001) and 59.8% (95% CI, 37.80 to 74.10; p < 0.001), respectively. A statistically significant association was found between AYUSH prophylactic medicine intake and clinical recovery more frequently by the 3rd day of illness (χ2 = 9.01; p = 0.002). Time to resolution of symptoms in the AYUSH intake group was on average 0.3 days earlier than in the non-intake group (p = 0.002).
Conclusion
AYUSH prophylactics were associated with statistically significant levels of protection against COVID-19 disease severity. Amongst these, previous intake of homeopathy or Siddha medicines was associated with some protection against moderate/severe illness and with a somewhat quicker clinical recovery. Prospective studies with experimental research design are needed to validate the findings of this study. Study registration Clinical Trials Registry—India (CTRI/2020/08/027000).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Research, Central Council for Research in Homeopathy Headquarters, Delhi, India.
- Epidemic Cell, Central Council for Research in Homeopathy Headquarters, Delhi, India.
- Department of Pathology, Vidhyadeep Homeopathic Medical College, Surat, Gujarat, India.
- Department of Gynaecology, C.D. Pachchigar Homeopathic Medical College, Surat, Gujarat, India.
- Department of F.M.T, C.D. Pachchigar Homeopathic Medical College, Surat, Gujarat, India.
- Department of Organon and Homeopathic Philosophy, C.D. Pachchigar Homeopathic Medical College, Surat, Gujarat, India.
Zitieren
APA
Chaudhary, A., Nayak, D., Pandey, S., Shastri, V., Kamble, M., Pendse, V., Prajapati, V., Vaidya, B., Rohit, H., Beedmani, S., Presswala, N., Patole, T., Bawaskar, R., Shinde, V., Datta, M., Rai, G., Prusty, U., Pal, P. P., Goli, S. P., …, & Khurana, A. (2024). Association between Usage of Prophylactic AYUSH Medicines and Disease Severity in COVID-19 Patients: A Retrospective Cohort Study. Homeopathy, 113(04), 211-222. https://doi.org/10.1055/s-0044-1779693
Vancouver
Chaudhary A, Nayak D, Pandey S, Shastri V, Kamble M, Pendse V, et al. Association between Usage of Prophylactic AYUSH Medicines and Disease Severity in COVID-19 Patients: A Retrospective Cohort Study. Homeopathy. 2024;113(04):211-222. doi:10.1055/s-0044-1779693
BibTeX
@article{Chaudhary2024,
author = {Chaudhary, Anupriya and Nayak, Debadatta and Pandey, Swati and Shastri, Vipul and Kamble, Madhuri and Pendse, Vidya and Prajapati, Vismay and Vaidya, Brijesh and Rohit, Heenal and Beedmani, Swaroopa and Presswala, Nutan and Patole, Tejaswini and Bawaskar, Ramesh and Shinde, Vaishali and Datta, Mohua and Rai, Gunjan and Prusty, Umakanta and Pal, Partha Pratim and Goli, Siva Prasad and Sahoo, Amulya Ratna and Muraleedharan, K C and Prakash, Pooja and Mahajan, Ashish and Singh, Anuradha and Krishnan, Reetha and Pawaskar, Navin and Srivastava, Amit and Ningthoujam, Gouri Devi and Sadarla, Ravi Kumar and Sonny, Ranjit and Karso, Liyi and Sarkar, Subhamoy and Prasad, Sunil and Shrivastava, Ashish Kumar and Kumar, Avinash and Kumar, Nitesh and Raveendar, Ch and Kumar, Bsj Raja and Sastry, Vspk and Dasari, Asha and Sundeep, K Samson and Kaushik, Subhash and Rath, Padmalaya and Gautam, Shweta and Shil, Ratan Chandra and Swain, Trupti Laxmi and Reddy, G Ravi Chandra and Pradeep, S and Stevenson, S and Choubey, Gurudev and Debata, Lipipushpa and Khurana, Anil},
title = {Association between Usage of Prophylactic AYUSH Medicines and Disease Severity in COVID-19 Patients: A Retrospective Cohort Study},
journal = {Homeopathy},
year = {2024},
volume = {113},
number = {04},
pages = {211--222},
doi = {10.1055/s-0044-1779693}
}
EUVIMED